ArticleMembranes2025
From Clever Composites to Credible Technologies.
Article in Membranes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Composite membranes are a hot topic in the field of membrane research. With the continuous progress of technology, its development has advanced from the application of simple copolymers to diversified material combinations. This Perspective examines why many composite membranes that excel in the lab struggle to deliver credible, durable performance at scale. Our aim is to connect four issues that are often treated in isolation-interfacial stability, manufacturability, data quality, and circular design-and to translate them into practical reporting and testing habits for the community. The novelty lies in treating "credibility" as the target function: we propose discipline-first guidelines that couple dynamic interfacial measurements with standardized long-run fouling and cleaning protocols, techno-economic and life-cycle reporting, and process-aware chemistry that fits existing hardware. We outline near-term applications in water treatment and resource recovery where drop-in formats and safer solvents already enable pilot-level operation. The future scope includes round-robin builds, FAIR data deposits, and durability metrics aligned with widely used standards for fouling potential and system benchmarking. Progress, we argue, will be measured less by first-day flux and more by what survives months of operation with uncertainty and costs on the page.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.